Revascularization of the heart is the prime objective following a myocardial infarction as the
morbidity inflicted severely impacts the patient's lifestyle and working capabilities. The use of …

Vascular diseases are the disease of arteries and veins, mediated by endothelial cell
dysfunctions, leading to blockage of vessels. Although bone marrow mononuclear cells and …

Introduction After receiving a diagnosis of congestive heart failure, one in five patients will be
dead within 12 months. 1 This condition affects at least 10 million people in Western Europe …

Ischemic heart disease (IHD) is a major cause of mortality and morbidity worldwide. It
caused 1 of every 6 deaths in the United States in 2008. Patients with serious IHD are …

Las enfermedades cardiovasculares, y dentro de ellas la insuficiencia cardíaca (IC), son
unas de las causas más frecuentes de morbimortalidad en el primer mundo. La principal …

Methods Design This is a prospective, randomized double-armed (controlled) clinical trial.
Participants: Thirty ischemic heart patients who were already scheduled for first-time isolated …

Cardiovascular investigators are currently investigating adult bone marrow stem cells,
cardiac stem cells, and adipose stem cells as potential new regenerative cell treatments for …

Bone marrow mononuclear cells (BMCs) were used as the initial cell population for
examining cell therapy in heart failure patients because of their accessibility and their …

Myocardial infarction typically is the result of atherosclerotic plaque rupture in a coronary
artery followed by platelet aggregation and thrombus formation resulting in partial or total …

Stem cells exert therapeutic effects for central nervous system (CNS) trauma. Accumulating
evidence reveals that stem cell-based therapies for CNS trauma can be achieved via …